Innoviz director reports 234,329 share holdings

Innoviz Technologies Ltd. director Orit Stav has reported initial ownership of 234,329 ordinary shares of the company.

Accepted by SEC EDGAR 03/18/2026 - 06:24 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Innoviz Technologies Ltd. director Orit Stav has reported initial ownership of 234,329 ordinary shares of the company. This Form 3 filing outlines the director’s current stake rather than any new share purchase or sale.

The reported holdings include 107,083 ordinary shares that are issuable upon vesting of restricted share units granted on May 13, 2025, which vest on April 5, 2026. Each RSU represents a contingent right to receive one ordinary share with no exercise price payable.

Insider Trade Summary

Holdings reported, no transactions

Holdings

Insider Stav Orit

Role Director

Type	Security	Shares	Price	Value
Holding	Ordinary Shares	--	--	--

Holdings: Ordinary Shares — 234,329 shares (Direct)

Footnotes (1)

1. F1. Includes 107,083 ordinary shares issuable upon vesting of restricted share units (RSUs) granted on May 13, 2025. The RSUs vest on April 5, 2026. Each RSU represents a contingent right to receive one ordinary share. No exercise price is applicable.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Innoviz (INVZ) Form 3 filing by Orit Stav show?

The Form 3 shows director Orit Stav holding 234,329 ordinary shares of Innoviz Technologies Ltd. The filing establishes her initial reported ownership position as a company insider, rather than documenting a new purchase or sale transaction.

How many Innoviz (INVZ) shares are tied to RSUs in this Form 3?

The filing states that 107,083 ordinary shares are issuable upon vesting of restricted share units. These RSUs were granted on May 13, 2025 and will vest on April 5, 2026, each converting into one ordinary share with no exercise price.

Is there a purchase or sale of Innoviz (INVZ) shares in this Form 3?

No purchase or sale is reported; the Form 3 records initial holdings for director Orit Stav. It lists a total of 234,329 ordinary shares, including 107,083 shares underlying restricted share units that will vest into ordinary shares at a future date.

What type of securities does the Innoviz (INVZ) Form 3 cover for Orit Stav?

The Form 3 covers ordinary shares of Innoviz Technologies Ltd. It reports 234,329 ordinary shares held directly, which include 107,083 ordinary shares issuable upon vesting of restricted share units, each RSU representing a contingent right to one share.

When do the Innoviz (INVZ) RSUs reported by Orit Stav vest?

The filing states that the restricted share units granted to Orit Stav on May 13, 2025 vest on April 5, 2026. Upon vesting, each RSU converts into one ordinary share of Innoviz Technologies Ltd., and no exercise price is required.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Stav Orit

(Last) (First) (Middle)

C/O INNOVIZ TECHNOLOGIES LTD.

5 URI ARIAV STREET, BUILDING C

(Street)

ROSH HA'AIN 4809202

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Innoviz Technologies Ltd. [ INVZ ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	234,329(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 107,083 ordinary shares issuable upon vesting of restricted share units (RSUs) granted on May 13, 2025. The RSUs vest on April 5, 2026. Each RSU represents a contingent right to receive one ordinary share. No exercise price is applicable.

Remarks:

[Exhibit 24 - Power of Attorney.]

	/s/ Dafna Raz - Attorney-in-Fact	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)